Literature DB >> 26232235

Differential effects of octanoate and heptanoate on myocardial metabolism during extracorporeal membrane oxygenation in an infant swine model.

Masaki Kajimoto1, Dolena R Ledee1, Aaron K Olson2, Nancy G Isern3, Christine Des Rosiers4, Michael A Portman5.   

Abstract

Nutritional energy support during extracorporeal membrane oxygenation (ECMO) should promote successful myocardial adaptation and eventual weaning from the ECMO circuit. Fatty acids (FAs) are a major myocardial energy source, and medium-chain FAs (MCFAs) are easily taken up by cell and mitochondria without membrane transporters. Odd-numbered MCFAs supply carbons to the citric acid cycle (CAC) via anaplerotic propionyl-CoA as well as acetyl-CoA, the predominant β-oxidation product for even-numbered MCFA. Theoretically, this anaplerotic pathway enhances carbon entry into the CAC, and provides superior energy state and preservation of protein synthesis. We tested this hypothesis in an immature swine model undergoing ECMO. Fifteen male Yorkshire pigs (26-45 days old) with 8-h ECMO received either normal saline, heptanoate (odd-numbered MCFA), or octanoate (even-numbered MCFA) at 2.3 μmol·kg body wt(-1)·min(-1) as MCFAs systemically during ECMO (n = 5/group). The 13-carbon ((13)C)-labeled substrates ([2-(13)C]lactate, [5,6,7-(13)C3]heptanoate, and [U-(13)C6]leucine) were systemically infused as metabolic markers for the final 60 min before left ventricular tissue extraction. Extracted tissues were analyzed for the (13)C-labeled and absolute concentrations of metabolites by nuclear magnetic resonance and gas chromatography-mass spectrometry. Octanoate produced markedly higher myocardial citrate concentration, and led to a higher [ATP]-to-[ADP] ratio compared with other groups. Unexpectedly, octanoate and heptanoate increased the flux of propionyl-CoA relative to acetyl-CoA into the CAC compared with control. MCFAs promoted increases in leucine oxidation, but were not associated with a difference in protein synthesis rate. In conclusion, octanoate provides energetic advantages to the heart over heptanoate.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cardiac metabolism; extracorporeal circulation; fatty acids; pediatrics

Mesh:

Substances:

Year:  2015        PMID: 26232235      PMCID: PMC4631540          DOI: 10.1152/ajpheart.00298.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  29 in total

1.  A.S.P.E.N. Clinical guidelines: nutrition support of neonates supported with extracorporeal membrane oxygenation.

Authors:  Tom Jaksic; Melissa A Hull; Biren P Modi; Y Avery Ching; Donald George; Charlene Compher
Journal:  JPEN J Parenter Enteral Nutr       Date:  2010 May-Jun       Impact factor: 4.016

Review 2.  Anaplerotic molecules: current and future.

Authors:  Henri Brunengraber; Charles R Roe
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  20-year experience of prolonged extracorporeal membrane oxygenation in critically ill children with cardiac or pulmonary failure.

Authors:  Punkaj Gupta; Rachel McDonald; Carl W Chipman; Michael Stroud; Jeffrey M Gossett; Michiaki Imamura; Adnan T Bhutta
Journal:  Ann Thorac Surg       Date:  2012-03-14       Impact factor: 4.330

4.  Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.

Authors:  Isaac Marin-Valencia; Levi B Good; Qian Ma; Craig R Malloy; Juan M Pascual
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

5.  In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins.

Authors:  Abdul Jaleel; Kevin R Short; Yan W Asmann; Katherine A Klaus; Dawn M Morse; G Charles Ford; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

6.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation.

Authors:  Colleen M O'Kelly Priddy; Masaki Kajimoto; Dolena R Ledee; Bertrand Bouchard; Nancy Isern; Aaron K Olson; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

7.  Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion.

Authors:  Aaron K Olson; Outi M Hyyti; Gordon A Cohen; Xue-Han Ning; Martin Sadilek; Nancy Isern; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

8.  Mass isotopomer study of anaplerosis from propionate in the perfused rat heart.

Authors:  Takhar Kasumov; Andrea V Cendrowski; France David; Kathryn A Jobbins; Vernon E Anderson; Henri Brunengraber
Journal:  Arch Biochem Biophys       Date:  2007-03-12       Impact factor: 4.013

Review 9.  Medium-chain fatty acids as metabolic therapy in cardiac disease.

Authors:  François Labarthe; Roselle Gélinas; Christine Des Rosiers
Journal:  Cardiovasc Drugs Ther       Date:  2008-04       Impact factor: 3.727

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

View more
  9 in total

1.  Right ventricular metabolism during venoarterial extracorporeal membrane oxygenation in immature swine heart in vivo.

Authors:  Masaki Kajimoto; Dolena R Ledee; Nancy G Isern; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

2.  Selective cerebral perfusion prevents abnormalities in glutamate cycling and neuronal apoptosis in a model of infant deep hypothermic circulatory arrest and reperfusion.

Authors:  Masaki Kajimoto; Dolena R Ledee; Aaron K Olson; Nancy G Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  J Cereb Blood Flow Metab       Date:  2016-09-07       Impact factor: 6.200

Review 3.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.

Authors:  Peter Schönfeld; Lech Wojtczak
Journal:  J Lipid Res       Date:  2016-04-14       Impact factor: 5.922

4.  Remodeling of substrate consumption in the murine sTAC model of heart failure.

Authors:  Aslan Turer; Francisco Altamirano; Gabriele G Schiattarella; Herman May; Thomas G Gillette; Craig R Malloy; Matthew E Merritt
Journal:  J Mol Cell Cardiol       Date:  2019-07-21       Impact factor: 5.000

Review 5.  Cardiovascular Metabolomics.

Authors:  Robert W McGarrah; Scott B Crown; Guo-Fang Zhang; Svati H Shah; Christopher B Newgard
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

6.  Microfluidic cell sorting: Towards improved biocompatibility of extracorporeal lung assist devices.

Authors:  Christian Bleilevens; Jonas Lölsberg; Arne Cinar; Maren Knoben; Oliver Grottke; Rolf Rossaint; Matthias Wessling
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

7.  Metabolic Response of the Immature Right Ventricle to Acute Pressure Overloading.

Authors:  Masaki Kajimoto; Muhammad Nuri; Nancy G Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  J Am Heart Assoc       Date:  2018-05-30       Impact factor: 5.501

8.  Metabolic Response to Stress by the Immature Right Ventricle Exposed to Chronic Pressure Overload.

Authors:  Masaki Kajimoto; Muhammad Nuri; Nancy G Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  J Am Heart Assoc       Date:  2019-08-27       Impact factor: 5.501

9.  Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart.

Authors:  Jacquelyn M Walejko; Bridgette A Christopher; Scott B Crown; Guo-Fang Zhang; Adrian Pickar-Oliver; Takeshi Yoneshiro; Matthew W Foster; Stephani Page; Stephan van Vliet; Olga Ilkayeva; Michael J Muehlbauer; Matthew W Carson; Joseph T Brozinick; Craig D Hammond; Ruth E Gimeno; M Arthur Moseley; Shingo Kajimura; Charles A Gersbach; Christopher B Newgard; Phillip J White; Robert W McGarrah
Journal:  Nat Commun       Date:  2021-03-15       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.